The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.

Hims’ hair care lineup does a great job supporting your existing ... Still, I wish they had a ketoconazole option for shampoo, since it would work so effectively in their hair loss lineup.

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

“A lot of people do question [the company’s] long-term viability,” he said, but he also commended Hims for “rolling with the times.” Although Hims’s stock has gone up 65 percent in the ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Shares of Hims & Hers rose 5.2% Monday after the telehealth provider ran an advertisement on Super Bowl Sunday highlighting the company's efforts to fight the obesity epidemic in America.